JXSS2500048 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(3.4) | Import Drug Application | 2025-04-16 | | Inibio Co Ltd;Beijing Yuzhuo Biotechnology Co Ltd | | | view |
JXSS2500004 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(3.1) | Import Drug Application | 2025-02-11 | | Q-MED International Trading (SHANGHAI) Co Ltd;Q-Med AB;Ipsen Pharma | | | view |
JYSB2400247 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(3.1) | Supplementary Application | 2024-11-30 | | Ajinomoto Althea Inc;Revance Therapeutics Inc | | | view |
JYSZ2400056 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | License Renew | 2024-10-18 | | Ipsen Biopharm Ltd;Ipsen Ltd;Beaufour-Ipsen (Tianjin) Pharmaceutical Co Ltd | | | view |
CXSS2400072 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(3.2) | New Drug Application | 2024-07-18 | | Lanzhou Biotechnique Development Co Ltd | | | view |
CXSS2400071 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(3.2) | New Drug Application | 2024-07-18 | | Lanzhou Biotechnique Development Co Ltd | | | view |
JYSB2400147 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2024-07-09 | | Abbvie Ltd;Allergan Pharmaceuticals Ireland | | | view |
JYSB2400146 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2024-07-09 | | Abbvie Ltd;Allergan Pharmaceuticals Ireland | | | view |
JYSB2400142 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2024-07-02 | | Abbvie Ltd;Allergan Pharmaceuticals Ireland | | | view |
JYSB2400141 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2024-07-02 | | Abbvie Ltd;Allergan Pharmaceuticals Ireland | | | view |
JYSB2400140 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2024-07-02 | | Abbvie Ltd;Allergan Pharmaceuticals Ireland | | | view |
JXSS2400051 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(3.4) | Import Drug Application | 2024-06-27 | | Huons BioPharma Co Ltd;Imeik Technology Development Co Ltd | | | view |
JYSB2400006 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2024-01-16 | | Abbvie Ltd;Allergan Pharmaceuticals Ireland | | | view |
JYSB2400008 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2024-01-16 | | Abbvie Ltd;Allergan Pharmaceuticals Ireland | | | view |
JYSB2400007 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2024-01-16 | | Abbvie Ltd;Allergan Pharmaceuticals Ireland | | | view |
JYSB2300221 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2023-12-22 | | Abbvie Ltd;Allergan Pharmaceuticals Ireland | | | view |
JYSB2300222 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products | Supplementary Application | 2023-12-22 | | Abbvie Ltd;Allergan Pharmaceuticals Ireland | | | view |
JTS2300039 | QM1114 | botulinum toxin type A | Lyophilized | Biological Products | Disposable Import Drug Application | 2023-07-20 | | Q-MED International Trading (SHANGHAI) Co Ltd;Q-Med AB | | | view |
JXSS2300053 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(2.2) | Import Drug Application | 2023-07-06 | | Shanghai Fosun Pharmaceutical Industrial Development Co Ltd;Revance Therapeutics Inc | | | view |
JXSS2300048 | 注射用A型肉毒毒素 | botulinum toxin type A | Lyophilized | Biological Products(2.2) | Import Drug Application | 2023-06-20 | | Abbvie Ltd;Allergan Consulting (Shanghai) Co Ltd;Allergan Pharmaceuticals Ireland | | | view |